Skip to content

Serotonin: all studies

Page 124 of 400: studies 1,231 to 1,240 of 3,999, newest first. Back to the serotonin overview

Research

Pathway engineering for the biosynthesis of psychedelics

Current Opinion in Biotechnology May 15, 2025 Zachary N. Abrahms, Abhishek K. Sen, J. Andrew Jones 2 citations

Naturally occurring psychoactive compounds have been used for cultural and ethnomedical purposes for centuries. Several more such molecules continue to be chemically synthesized, exhibiting a wide range of potency, therapeutic, and hallucinogenic effects. Promising clinical data and a renewed interest in understanding the cellular mechanisms of action have inspired synthetic biology efforts to...

Can the gut-brain axis provide insight into psilocybin's therapeutic value in reducing stress?

Neurobiology of Stress May 1, 2025 Alanna Kit, Kate Conway, Savannah Makarowski et al. 5 citations

There is growing interest in exploring the therapeutic potential and mechanisms of action of psilocybin on stress-related neuropsychiatric disorders, including depression, generalized anxiety disorder (GAD), post-traumatic stress disorder (PTSD), obsessive-compulsive disorder (OCD), addiction, and disordered eating. Despite promising progressions in preclinical and clinical research, the...

DOI: 10.1016/j.ynstr.2025.100732 (opens in new tab) 5-HT Psilocybin Inflammation Neuropsychiatric disorders +7

Psilocybin and ketamine affect novel neuropeptides gene expression in the rat hypothalamus

Journal of Psychopharmacology April 17, 2025 Artur Pałasz, Marta Pukowiec, Katarzyna Bogus et al.

Objective: Psychedelics are able to trigger highly intense and profound alterations in self-consciousness, perception, affective, and cognitive processes. Indeed, recent studies show that ketamine and psilocybin could be used as fast-acting antidepressants. However, the molecular and neurochemical mechanisms of these psychedelics and their actions at the level of diverse brain structures...

Behavioral effects of three synthetic tryptamine derivatives in rodents.

Journal of Psychopharmacology April 4, 2025 Rebecca D. Hill, Ritu A. Shetty, Nathalie Sumien et al.

New synthetic tryptamine derivatives have emerged in the underground market. They act on serotonin receptors mimicking the effects of hallucinogenic drugs such as DOM. The DEA has identified three tryptamine derivatives of concern, 5-MeO-DBT, 5-Cl-DMT, and 4-OH-MiPT. Swiss Webster mice were tested for locomotor activity. Discriminative stimulus effects were tested in male Sprague-Dawley rats...

DOI: 10.1177/02698811251330737 (opens in new tab) Full text (opens in new tab) Serotonin Drug discrimination Hallucinogens psychedelics Entheogens +4

Xylazine as an emerging new psychoactive substance; focuses on both 5‐HT7 and κ‐opioid receptors' molecular interactions and isosteric replacement

Archiv der Pharmazie March 1, 2025 Giuseppe Floresta, Alberto Granzotto, Vincenzo Patamia et al. 12 citations

Abstract Xylazine, traditionally used as a veterinary sedative, has recently emerged as a new psychoactive substance, being typically ingested in combination with fentanyl derivatives and hence raising significant public health concerns. Despite its increasing prevalence, little is known about its molecular interactions with human neuroreceptors, specifically the serotonin 7 (5‐HT 7 R) and...

The Selective 5HT2A Receptor Agonist, 25CN-NBOH Exerts Excitatory and Inhibitory Cellular Actions on Mouse Medial Prefrontal Cortical Neurons.

Synapse March 1, 2025 Yang Wang, Jesper L. Kristensen, Kristi A. Kohlmeier 5 citations

Psychedelic compounds have gained renewed interest due to their rapid and long-lasting therapeutic effects on stress-related disorders. While the underlying mechanisms of therapeutic actions of psychedelic compounds are still unclear, these drugs are thought to modulate the activity of the serotonergic system, primarily through activating serotonin type 2A receptor (5-HT2AR) and studies have...

DOI: 10.1002/syn.70014 (opens in new tab) Full text (opens in new tab) Serotonin Action potential Brain slices Electrophysiological recordings +1

Brain acid sphingomyelinase controls addiction-related behaviours in a sex-specific way.

Neurobiology of Disease March 1, 2025 Liubov S. Kalinichenko, Iulia Zoicas, Anne-Marie Bienia et al. 4 citations

Addiction is a chronic and severe mental disorder with high gender- and sex-specificity. However, the pathogenesis of this disorder is not fully elucidated, and no targeted pharmacotherapy is available. A growing body of evidence points out the potential involvement of the ceramide system in the pathophysiology of addiction. A pathogenic pathway for several mental disorders based on the...

Cardiac effects of two hallucinogenic natural products, N,N-dimethyl-tryptamine and 5-methoxy-N,N-dimethyl-tryptamine.

Scientific Reports February 25, 2025 Joachim Neumann, Tobias Dietrich, Karyna Azatsian et al. 2 citations

It is unclear whether hallucinogenic tryptamine derivatives namely N,N-dimethyl-tryptamine (DMT) and 5-methoxy-N,N-dimethyl-tryptamine (5-MeO-DMT) exert positive inotropic effects in the human heart. Therefore, we measured the inotropic effects of these drugs in isolated left and right atrial preparations of mice that overexpress human 5-HT4 receptors (5-HT4-TG) and preparations from wild type...

DOI: 10.1038/s41598-025-91400-6 (opens in new tab) Full text (opens in new tab) Serotonin sign N,N-Dimethyl-Tryptamine DMT 5-ht4 receptor 5-Methoxy-N,N-Dimethyl-Tryptamine 5-MEO-DMT +8

The Effect of Psilocybin on Cortical Neural Dynamics, Sleep-Wake Behavior, and Persistent Pain in a Rat Model

University of Michigan Library 2025 Nicholas Kolbman

Psilocybin containing mushrooms have been utilized for ceremonial, medicinal, and spiritual purposes for millennia. Recently there has been a surge of scientific interest in the therapeutic potential and mechanistic understanding of serotonergic psychedelics, including psilocybin. Psilocybin is classified as a serotonergic psychedelic because the non-ordinary state of consciousness that it...

Antidepressant and anxiolytic effects of activating 5HT2A receptors in the anterior cingulate cortex and the theoretical mechanisms underlying them - A scoping review of available literature.

Brain Research 2025 Leonor Miranda 59 citations

Psychedelic drugs that activate the 5HT2A receptor have long been the target of extensive clinical research, particularly in models of psychiatric illness. The aim of this literature review was to investigate the therapeutic effects of 5HT2A receptor activation in the anterior cingulate cortex (ACC) and the respective mechanisms that underlie them. Based on the available research, I suggest...